Mirum Pharmaceuticals, Inc. (MIRM) is listed on NASDAQ in Pharmaceutical Stocks. It is $97.41, -2.35%, with a $6.3B market cap. RSI is 36.9, near oversold. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 36.9 Near Oversold
Market Cap $6.3B
Volume 420.1K
Fundamentals — 10-Q Q2 2026
Revenue $336.1M
Net Income $-857.4M
EPS $-14.03
Operating Margin -247.5%
Net Margin -255.1%
P/E Ratio -6.9x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 40,000 | $100.00 | $4.0M | 2026 Aug 18 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Sell | 6,001 | $99.90 | $599,510 | 2026 Aug 11 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 20,000 | $98.92 | $2.0M | 2026 Aug 10 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 1,840 | $105.29 | $193,734 | 2026 Aug 3 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 20,000 | $122.27 | $2.4M | 2026 Jul 6 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Sell | 5,000 | $122.25 | $611,273 | 2026 Jul 6 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,721 | $120.00 | $326,520 | 2026 Jul 1 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 2,594 | $101.95 | $264,458 | 2026 Jun 17 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Sell | 5,000 | $93.82 | $469,077 | 2026 Jun 8 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 30,000 | $95.84 | $2.9M | 2026 Jun 1 |
| Ramasastry Saira | Insider | Sell | 3,977 | $100.00 | $397,700 | 2026 Jun 1 |
| Ramasastry Saira | Insider | Sell | 2,000 | $109.47 | $218,940 | 2026 May 15 |
| Ramasastry Saira | Insider | Sell | 2,000 | $96.90 | $193,800 | 2026 Apr 15 |
| Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Sell | 7,287 | $91.98 | $670,243 | 2026 Mar 16 |
| Quan Joanne | CHIEF MEDICAL OFFICER | Sell | 7,287 | $91.98 | $670,243 | 2026 Mar 16 |
| Ramasastry Saira | Insider | Sell | 2,000 | $90.76 | $181,520 | 2026 Mar 16 |
| Radovich Peter | PRESIDENT AND COO | Sell | 16,515 | $91.98 | $1.5M | 2026 Mar 16 |
| Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | 4,732 | $91.98 | $435,239 | 2026 Mar 16 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | 40,985 | $91.98 | $3.8M | 2026 Mar 16 |
| Ramasastry Saira | Director | Sell | 5,000 | $80.00 | $400,000 | 2025 Dec 22 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $48.69 | 60.7 | $3.1B |
| | $67.67 | 38.4 | $6.1B |
| | $59.99 | 39.6 | $5.8B |
Take MIRM further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put MIRM in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Mirum Pharmaceuticals, Inc. next reports.
Set alerts on MIRM
Get notified when Mirum Pharmaceuticals, Inc. hits your price targets or technical conditions are met.
Get Started Free